Skip to main content

Advertisement

SpringerLink
Log in

J-SKI will be able to elucidate whether the renal function recover or not after discontinuation of tyrosine kinase inhibitors

  • Letter to the Editor
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Reference

  1. Okamoto S, Ureshino H, Kawaguchi A, Miyazono M, Ikeda Y, Kimura S. Assessment of estimated glomerular filtration rate in patients with chronic myeloid leukemia following discontinuation of tyrosine kinase inhibitors. Int J Hematol. 2020;112:41–45.

  2. Ikeda N, Sapienz D, Guerrero R, Aekplakorn W, Naghavi M, Mokdad AH, et al. Control of hypertension with medication: a comparative analysis of national surveys in 20 countries. Bull World Health Organ. 2014;92:10.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology, Respiratory Medicine and Oncology, Department of Internal Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan

    Sho Okamoto, Hiroshi Ureshino & Shinya Kimura

  2. Department of Drug Discovery and Biomedical Sciences, Saga University, Saga, Japan

    Hiroshi Ureshino & Shinya Kimura

Authors
  1. Sho Okamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hiroshi Ureshino
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shinya Kimura
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hiroshi Ureshino.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Okamoto, S., Ureshino, H. & Kimura, S. J-SKI will be able to elucidate whether the renal function recover or not after discontinuation of tyrosine kinase inhibitors. Int J Hematol 112, 429–430 (2020). https://doi.org/10.1007/s12185-020-02945-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-020-02945-3

Search

Navigation